These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 4569219

  • 1. Clinical evaluation of chlorazepate, a new ataractic.
    Holmgren S.
    Nord Psykiatr Tidsskr; 1973; 27(1):40-4. PubMed ID: 4569219
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clorazepate dipotassium in anxiety: a clinical trial with diazepam and placebo controls.
    Ricca JJ.
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):286-90. PubMed ID: 4557537
    [No Abstract] [Full Text] [Related]

  • 4. The differentiation of anxiety and depressive disorders: a psychopharmacological approach.
    Zung WW.
    Psychosomatics; 1973 Jul; 14(6):362-6. PubMed ID: 4795102
    [No Abstract] [Full Text] [Related]

  • 5. Clinical trial of dipotassium chlorazepate, a new benzodiazepine derivative.
    Juhlin L, Opitz B.
    Nord Psykiatr Tidsskr; 1973 Jul; 27(1):35-9. PubMed ID: 4569218
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Trial of dipotassium chlorazepate in child psychiatry].
    Launay C, Houzel D.
    Rev Neuropsychiatr Infant; 1972 May; 20(5):491-5. PubMed ID: 5081843
    [No Abstract] [Full Text] [Related]

  • 11. Clorazepate dipotassium, diazepam and placebo in chronic anxiety.
    Feurst SI.
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):449-59. PubMed ID: 4198306
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Our experience with Tranxene in adaptation pathology].
    de Boucaud M, Gachie JP, Hubert LM, Valencon J.
    Bord Med; 1972 Mar; 5(5):563-74. PubMed ID: 5071679
    [No Abstract] [Full Text] [Related]

  • 17. [Injectable clorazepate in ethylism complications in O.R.L. surgery].
    Gignoux B.
    J Med Lyon; 1972 May 05; 53(228):695-6. PubMed ID: 4563480
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clorazepate dipotassium: a new benzodiazepine antianxiety agent.
    Charalampous KD, Tooley W, Yates C.
    J Clin Pharmacol New Drugs; 1973 May 05; 13(2):114-8. PubMed ID: 4568296
    [No Abstract] [Full Text] [Related]

  • 20. Somatosensory evoked potential: an objective indicator of the therapy efficacy of a new psychotropic drug, clorazepate dipotassium (tranxene).
    Saletu B, Saletu M, Itil TM.
    Curr Ther Res Clin Exp; 1972 Aug 05; 14(8):428-41. PubMed ID: 4629305
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.